Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chahroudi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Methods (San Diego, Calif.)|September 6, 2003
Measuring T cell-mediated cytotoxicity using fluorogenic caspase substratesA Chahroudi, G Silvestri, M B Feinberg
Blood|August 10, 1999
Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virusM Subklewe, A Chahroudi, A Schmaljohn, et al.
European Journal of Immunology|December 22, 1999
Presentation of epstein-barr virus latency antigens to CD8(+), interferon-gamma-secreting, T lymphocytesM Subklewe, A Chahroudi, K Bickham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasionJ Engelmayer, M Larsson, M Subklewe, et al.
The Journal of Experimental Medicine|May 17, 2000
Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1C Münz, K L Bickham, M Subklewe, et al.
Journal of Virology|October 18, 2019
Pharmacological Modulation of the Wnt/β-Catenin Pathway Inhibits Proliferation and Promotes Differentiation of Long-Lived Memory CD4<sup>+</sup> T Cells in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected MacaquesM Mavigner, M Zanoni, G K Tharp, et al.
Journal of Virus Eradication|March 13, 2023
Highlights from the Tenth International Workshop on HIV Persistence during Therapy, December 13-16, 2022, Miami, Florida-USAN Archin, K J Bar, T Burdo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Methods (San Diego, Calif.)|September 6, 2003
Measuring T cell-mediated cytotoxicity using fluorogenic caspase substratesA Chahroudi, G Silvestri, M B Feinberg
Blood|August 10, 1999
Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virusM Subklewe, A Chahroudi, A Schmaljohn, et al.
European Journal of Immunology|December 22, 1999
Presentation of epstein-barr virus latency antigens to CD8(+), interferon-gamma-secreting, T lymphocytesM Subklewe, A Chahroudi, K Bickham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasionJ Engelmayer, M Larsson, M Subklewe, et al.
The Journal of Experimental Medicine|May 17, 2000
Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1C Münz, K L Bickham, M Subklewe, et al.
Journal of Virology|October 18, 2019
Pharmacological Modulation of the Wnt/β-Catenin Pathway Inhibits Proliferation and Promotes Differentiation of Long-Lived Memory CD4<sup>+</sup> T Cells in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected MacaquesM Mavigner, M Zanoni, G K Tharp, et al.
Journal of Virus Eradication|March 13, 2023
Highlights from the Tenth International Workshop on HIV Persistence during Therapy, December 13-16, 2022, Miami, Florida-USAN Archin, K J Bar, T Burdo, et al.
Pageof 1